KRISTEN BADAWY: Open Payments
NPI 1639723042 · WYNDMOOR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 86 payments from 16 companies in 2025. Trend: 2023 $587 · 2024 $524 · 2025 $1,937
Food & beverage: $1,708Education: $229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $494 |
| Janssen Biotech, Inc. | 7 | $263 |
| E.R. Squibb & Sons, L.L.C. | 10 | $227 |
| Galderma Laboratories, L.P. | 11 | $162 |
| Organon LLC | 14 | $155 |
| GENZYME CORPORATION | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| REVANCE THERAPEUTICS, INC. | 1 | $97 |
| UCB, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
Products named: TREMFYA, Sotyktu, DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, DAXXIFY, Bimzelx.
Industry payments across PA — which companies pay providers there.
